Bravias Capital Group, LLC Abb Vie Inc. Transaction History
Bravias Capital Group, LLC
- $150 Billion
- Q3 2025
A detailed history of Bravias Capital Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bravias Capital Group, LLC holds 969 shares of ABBV stock, worth $212,366. This represents 0.15% of its overall portfolio holdings.
Number of Shares
969Holding current value
$212,366% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
4,423Shares Held
1.3BCall Options Held
16.1MPut Options Held
10.9M-
Vanguard Group Inc Valley Forge, PA178MShares$39 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$29.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$17.5 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$12.4 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.14 Billion0.52% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $387B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...